Express Pharma

Alembic Pharma receives EIR from US FDA

4

The inspection was carried at the formulation facility located at Panelav, Gujarat

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from the US health regulator for its formulation facility located at Panelav in Gujarat.

“The company has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) for the inspection carried out by them at our formulation facility at Panelav during the period from March 12-20, 2018,” Alembic Pharmaceuticals said in a BSE filing.

US FDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.

 

 

Comments are closed.